Results of Conventional Radiotherapy in Hypopharyngeal Cancer

하인두암의 방사선 치료 성적

  • Nam, Taek-Keun (Department of Therapeutic Radiology Chonnam University Medical School) ;
  • Park, Seung-Jin (Department of Radiology, Gyeongsang University Hospital) ;
  • Ahn, Sung-Ja (Department of Therapeutic Radiology Chonnam University Medical School) ;
  • Chung, Woong-Ki (Department of Therapeutic Radiology Chonnam University Medical School) ;
  • Nah, Byung-Sik (Department of Therapeutic Radiology Chonnam University Medical School)
  • 남택근 (전남대학교 의과대학 치료방사선과학교실) ;
  • 박승진 (경상대학교병원 방사선과) ;
  • 안성자 (전남대학교 의과대학 치료방사선과학교실) ;
  • 정웅기 (전남대학교 의과대학 치료방사선과학교실) ;
  • 나병식 (전남대학교 의과대학 치료방사선과학교실)
  • Published : 1995.06.01

Abstract

Purpose: We tried to evaluate the role of conventional radiotherapy alone or with neoadjuvant chemotherapy in the hypopharyngeal cancer by retrospective analysis. Materials and Methods: Between Jul.1985 and Sep.1992, 42 patients of hypopharyngeal cancer were treated by conventional radiotherapy alone or combined with neoadjuvant chemotherapy. The male to female ratio was 20:1 with a median age of 58 years, Twelve Patients were treated by conventional radiotherapy alone and 30 patients were treated by neoadjuvant chemotherapy and radiotherapy. Results: Seven Patients were Stage I,II and the patients with stage III and IV were 10 and 25, respectively at the time of presentation. The overall survival and disease-specific survival rates at 24 months were $12.9\%$ and $15.5\%,$respectively Two-year survival rates of stage I+II and III+IV patients were $50\%$ and $6.3\%,$ respectively(p(0.05). Sixteen Patients$(38\%)$ revealed CR and 26 patients$(62\%)$ revealed less than CR at the end of radiotherapy and their 2-year survival rates were $31.3\%\;and\;0\%,$ respectively(p(0.05). On univariate analysis, stage, T-stage, N-stage and treatment response were the significant prognostic factors, but only stage and treatment response were significant on multivariate analysis Conclusion : This conventional radiotherapy alone or with neoadjuvant chemotherapy does not seem to be sufficient in the treatment of most advanced hypopharyngeal cancer Therefore other treatment modalities such as hyperfractionation or concurrent chemoradiotherapy should be considered.